Inovio Pharmaceuticals Inc. share price logo

Inovio Pharmaceuticals Inc.

NASDAQ: INO

$0.66

-0.38

(-36.92%)

as on

Inovio Pharmaceuticals Inc. Stock Performance

as on July 31, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.56
    $0.73
    downward going graph

    14.63%

    Downside

    11.28%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.95
    $2.98
    downward going graph

    -44.85%

    Downside

    354.10%

    Upside

    downward going graph

Inovio Pharmaceuticals Inc. share price movements today

Previous Close
$1.04
Open
$0.73
Volume
30.7M
Day's Low - High
$0.56 - $0.73
52 Week Low - High
$0.95 - $2.98

Inovio Pharmaceuticals Inc. Historical Returns

1 Month Return
-12.61 %
3 Month Return
-5.45 %
1 Year Return
-26.76 %
3 Year Return
-83.71 %
5 Year Return
-98.97 %

Inovio Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Inovio Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$79.4M

EPS (TTM)

-1.14

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-82.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-296.36%

Inovio Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Inovio Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$79.4M-98.97%NA0.00%NA
BUY$39.1B531.7%NA0.00%NA
BUY$124.5B139.77%28.4135.51%NA
BUY$72.9B21.02%16.2929.65%0.54%

Stock Returns calculator for Inovio Pharmaceuticals Inc. Stock including INR - Dollar returns

The Inovio Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Inovio Pharmaceuticals Inc. investment value today

Current value as on today

₹50,406

Returns

-₹49,594

(-49.59%)

Returns from Inovio Pharmaceuticals Inc. Stock

-₹53,803 (-53.8%)

Dollar Impact

₹4,209 (+4.21%)

Analyst Recommendation on Inovio Pharmaceuticals Inc. Stock

Based on 9 analysts

BUY

55.56%

Buy

44.44%

Hold

0.00%

Sell

Based on 9 analysts, 55.56% of analysts recommend a 'BUY' rating for Inovio Pharmaceuticals Inc.. Average target price of $3.43

Inovio Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Inovio Pharmaceuticals Inc..

What analysts predicted

80.87%UPSIDE

Target Price

$3.43

Current Price

$0.656

Analyzed by

9 Analysts

Target

$3.43

Inovio Pharmaceuticals Inc. target price $3.43, a slight upside of 80.87% compared to current price of $0.656. According to 9 analysts rating.

Indian Investors' Interest in Inovio Pharmaceuticals Inc. Stock

Search interest for Inovio Pharmaceuticals Inc. Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-38% versus previous 30 day period

Inovio Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
-
0
-
0
0
-
-
0
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-27
-31
-33
-27
-20
-25
-23
-21
-17
-21
EBITDA
-24
-29
-31
-24
-18
-25,050
-22
-44
4
-18
Interest Expense
0
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-25
-30
-32
-25
-19
-19
-23
-45
3
-19
Income Tax Expense
0
0
0
-
0
-
-
-
-
-
Net Income
-25
-30
-32
-25
-19
-19
-23
-45
3
-19
Net Profit Margin
-24357.91%
0.00%
-31993.31%
0.00%
-16566.39%
-30140.48%
0.00%
0.00%
-5761.72%
0.00%

Inovio Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
35
42
30
4
7
1
10
0
0
0
Gross Profit
35
42
30
4
7
1
10
0
-2
0
Operating Income
-76
-83
-94
-111
-124
-301
-267
-143
-112
-86
EBITDA
-74
-84
-89
-107
-149
-296
-270
-130
-103
-81
Interest Expense
0
0
0
7
8
1
1
1
0
-
Depreciation
-
3
4
5
4
4
5
4
3
2
Income Before Tax
-73
-88
-94
-120
-167
-303
-279
-135
-107
-84
Income Tax Expense
-4
1
2
0
52
0
2
0
-107,146
-
Net Income
-73
-88
-96
-119
-166
-303
-279
-135
-107
-84
Net Profit Margin
-208.49%
-208.92%
-318.12%
-2902.75%
-2245.39%
-17109.87%
-2726.67%
-16239.87%
-49254.27%
-130000.00%

Inovio Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-30
-32
-87
-19
-19
-23
-45
3
-19
Operating Cash Flow
-28
-28
-84
-19
-26
-20
-21
-19
-21
Investing Cash Flow
45
9
69,371
34
0
5
8
0
2
Financing Cash Flow
-11
33
0
29
1
0
24
27
0
Change in Cash
5
14
-12
44
-25
-15
12
7
-18

Inovio Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-88
-96
-120
-167
-303
-279
-135
-107
-84
Operating Cash Flow
-63
-73
-97
-177
-215
-216
-124
-104
-88
Investing Cash Flow
-27
42
-9
-58
-175
109
87
104
14
Financing Cash Flow
95
31
105
465
211
81
4
51
53
Change in Cash
4
0
-1
228
-179
-24
-32
51
-21

Global Institutional Holdings in Inovio Pharmaceuticals Inc.

Funds
Holdings
HHG PLC
4.02%
ADAR1 Capital Management LLC
1.79%
Geode Capital Management, LLC
0.97%
Goldman Sachs Group Inc
0.26%
Two Sigma Investments LLC
0.47%

Insights on Inovio Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, INO stock has moved up by 7.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 589.2% return, outperforming this stock by 672.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 385.4% return, outperforming this stock by 412.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 116.99K → -65.34K (in $), with an average decrease of 122.1% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 3.76M → -19.68M (in $), with an average decrease of 622.8% per quarter

About Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company's lead product candidate is INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade squamous intraepithelial lesions; INO-3112 for the treatment of HPV-related Oropharyngeal squamous cell carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 2/3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. The company's partners and collaborators ApolloBio Corporation, AstraZeneca, Coherus Biosciences, Defense Advanced Research Projects Agency, HIV Vaccines Trial Network, Kaneka Eurogentec, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the University of Pennsylvania, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.
OrganisationInovio Pharmaceuticals Inc.
Headquarters660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
IndustryBiotechnology
CEODr. Jacqueline E. Shea Ph.D.
E-voting on sharesClick here to vote

Key Management of Inovio Pharmaceuticals Inc.

Name

Title

Mr. E. J. Brandreth MBA

Senior Vice President of Quality Assurance

Mr. Robert J. Juba Jr.

Senior Vice President of Biological Manufacturing & Clinical Supply Management

Dr. Jacqueline E. Shea Ph.D.

CEO, President & Director

Dr. Michael Sumner B.S., M.B.A., M.D.

Chief Medical Officer & Head of Development

Dr. Laurent M. Humeau Ph.D.

Chief Scientific Officer & Chairman of the Scientific Advisory Board

Mr. Robert L. Crotty J.D.

General Counsel, Corporate Secretary & Chief Compliance Officer

Mr. Peter D. Kies

Chief Financial Officer

Ms. Jennie Willson

Director of Communications

Dr. Jeffrey Skolnik M.D.

Senior Vice President of Clinical Development

Mr. Shawn D. Bridy M.A., M.B.A.

Senior Vice President of Business Development

FAQs

What is Inovio Pharmaceuticals Inc. share price today?

Inovio Pharmaceuticals Inc. share price today is $0.66 as on at the close of the market. Inovio Pharmaceuticals Inc. share today touched a day high of $0.73 and a low of $0.56.

What is the 52 week high and 52 week low for Inovio Pharmaceuticals Inc. share?

Inovio Pharmaceuticals Inc. share touched a 52 week high of $2.98 on and a 52 week low of $0.95 on . Inovio Pharmaceuticals Inc. stock price today i.e. is closed at $0.66,which is 77.98% down from its 52 week high and -30.96% up from its 52 week low.

What is Inovio Pharmaceuticals Inc.'s market capitalisation today?

Inovio Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in Inovio Pharmaceuticals Inc. Stock (INO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Inovio Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inovio Pharmaceuticals Inc. Shares that will get you 2.2866 shares as per Inovio Pharmaceuticals Inc. share price of $0.66 per share as on July 31, 2026 at 8:46 am IST.

What is the minimum amount required to buy Inovio Pharmaceuticals Inc. Stock (INO) from India?

Indian investors can start investing in Inovio Pharmaceuticals Inc. (INO) shares with as little as ₹95.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.80 in Inovio Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Inovio Pharmaceuticals Inc. share’s latest price of $0.66 as on July 31, 2026 at 8:46 am IST, you will get 15.2439 shares of Inovio Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Inovio Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Inovio Pharmaceuticals Inc. stock has given -98.97% share price returns and 29.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?